|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.730 USD | +1.36% |
|
-5.45% | -42.26% |
| 05-14 | Aquestive Therapeutics, Inc., Q1 2026 Earnings Call, May 14, 2026 | |
| 05-13 | Aquestive Therapeutics Inc - enters five-year term loan facility of up to $150 million on May 12, 2026 - SEC filing | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Other Pharmaceuticals | +1.36% | -5.45% | -42.26% | -10.12% | +10.36% | 468M |  |  | |
- Stock Market
- Stocks
- AQST Stock
- Charts Aquestive Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
